Cypress Capital Group Iqvia Holdings Inc. Transaction History

Cypress Capital Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$210.56 - $273.58 $220,245 - $286,164	-1,046 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$238.37 - $282.61 $41,953 - $49,739	176 Added 20.23%	1,046 $295,000
Q3 2021 Oct 12, 2021	BUY	$239.54 - $265.23 $4,790 - $5,304	20 Added 2.35%	870 $208,000
Q2 2021 Jul 13, 2021	BUY	$198.06 - $246.77 $168,351 - $209,754	850 New	850 $206,000
Q1 2021 Apr 14, 2021	SELL	$173.0 - $194.59 $205,178 - $230,783	-1,186 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$153.99 - $180.39 $18,324 - $21,466	-119 Reduced 9.12%	1,186 $212,000
Q3 2020 Oct 08, 2020	BUY	$141.28 - $169.75 $184,370 - $221,523	1,305 New	1,305 $206,000

1,097

155M

227K

1.16M

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $44B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.